These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

996 related articles for article (PubMed ID: 25678787)

  • 1. Liposomes as nanomedical devices.
    Bozzuto G; Molinari A
    Int J Nanomedicine; 2015; 10():975-99. PubMed ID: 25678787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Progress in Liposome Production, Relevance to Drug Delivery and Nanomedicine.
    Koynova R; Tenchov B
    Recent Pat Nanotechnol; 2015; 9(2):86-93. PubMed ID: 27009123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.
    Pownall HJ; Rosales C; Gillard BK; Ferrari M
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):146-150. PubMed ID: 27826368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process Variables and Design of Experiments in Liposome and Nanoliposome Research.
    Zoghi A; Khosravi-Darani K; Omri A
    Mini Rev Med Chem; 2018; 18(4):324-344. PubMed ID: 27804889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based nanovesicles for nanomedicine.
    Grimaldi N; Andrade F; Segovia N; Ferrer-Tasies L; Sala S; Veciana J; Ventosa N
    Chem Soc Rev; 2016 Nov; 45(23):6520-6545. PubMed ID: 27722570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
    Rudokas M; Najlah M; Alhnan MA; Elhissi A
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes].
    Budai M; Szógyi M
    Acta Pharm Hung; 2001; 71(1):114-8. PubMed ID: 11769091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of liposomes with cells in vitro and in vivo: opsonins and receptors.
    Ishida T; Harashima H; Kiwada H
    Curr Drug Metab; 2001 Dec; 2(4):397-409. PubMed ID: 11766990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic Investigation of the Effect of Liposome Surface Charge on Drug Delivery in Microcirculation.
    D'Apolito R; Bochicchio S; Dalmoro A; Barba AA; Guido S; Tomaiuolo G
    Curr Drug Deliv; 2017; 14(2):231-238. PubMed ID: 27527074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-targeted liposome design: challenges and fundamental considerations.
    Noble GT; Stefanick JF; Ashley JD; Kiziltepe T; Bilgicer B
    Trends Biotechnol; 2014 Jan; 32(1):32-45. PubMed ID: 24210498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What nanomedicine in the clinic right now really forms nanoparticles?
    Svenson S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):125-35. PubMed ID: 24415653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From conventional to stealth liposomes: a new Frontier in cancer chemotherapy.
    Cattel L; Ceruti M; Dosio F
    J Chemother; 2004 Nov; 16 Suppl 4():94-7. PubMed ID: 15688621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeled liposomes and lipoproteins as lipidic nanoparticles for imaging and therapy.
    Aranda-Lara L; Morales-Avila E; Luna-Gutiérrez MA; Olivé-Alvarez E; Isaac-Olivé K
    Chem Phys Lipids; 2020 Aug; 230():104934. PubMed ID: 32562666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.
    Man F; Gawne PJ; T M de Rosales R
    Adv Drug Deliv Rev; 2019 Mar; 143():134-160. PubMed ID: 31170428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.